These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. An update on clinical trials for cutaneous lupus erythematosus. Xie L; Lopes Almeida Gomes L; Stone CJ; Faden DF; Werth VP J Dermatol; 2024 Jul; 51(7):885-894. PubMed ID: 38491743 [TBL] [Abstract][Full Text] [Related]
6. Cutaneous and systemic connections in lupus. Maz MP; Michelle Kahlenberg J Curr Opin Rheumatol; 2020 Nov; 32(6):583-589. PubMed ID: 32826479 [TBL] [Abstract][Full Text] [Related]
7. Management of cutaneous manifestations of lupus erythematosus: A systematic review. Fairley JL; Oon S; Saracino AM; Nikpour M Semin Arthritis Rheum; 2020 Feb; 50(1):95-127. PubMed ID: 31526594 [TBL] [Abstract][Full Text] [Related]
8. Brief report: responses to rituximab suggest B cell-independent inflammation in cutaneous systemic lupus erythematosus. Vital EM; Wittmann M; Edward S; Md Yusof MY; MacIver H; Pease CT; Goodfield M; Emery P Arthritis Rheumatol; 2015 Jun; 67(6):1586-91. PubMed ID: 25707733 [TBL] [Abstract][Full Text] [Related]
9. Current role of rituximab in systemic lupus erythematosus. Mok CC Int J Rheum Dis; 2015 Feb; 18(2):154-63. PubMed ID: 25522652 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic approach and treatment of cutaneous lupus erythematosus. Sticherling M; Bonsmann G; Kuhn A J Dtsch Dermatol Ges; 2008 Jan; 6(1):48-59. PubMed ID: 18190433 [TBL] [Abstract][Full Text] [Related]
13. Hair and Scalp Changes in Cutaneous and Systemic Lupus Erythematosus. Udompanich S; Chanprapaph K; Suchonwanit P Am J Clin Dermatol; 2018 Oct; 19(5):679-694. PubMed ID: 29948959 [TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of cutaneous lupus erythema associated with and without systemic lupus erythema. Zhang YP; Wu J; Han YF; Shi ZR; Wang L Autoimmun Rev; 2017 Jul; 16(7):735-742. PubMed ID: 28483542 [TBL] [Abstract][Full Text] [Related]
15. Cutaneous lupus erythematosus: updates on pathogenesis and associations with systemic lupus. Stannard JN; Kahlenberg JM Curr Opin Rheumatol; 2016 Sep; 28(5):453-9. PubMed ID: 27270345 [TBL] [Abstract][Full Text] [Related]
16. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity. Ugarte A; Porta S; RĂos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998 [TBL] [Abstract][Full Text] [Related]
18. Emerging immunotherapeutic strategies for cutaneous lupus erythematosus: an overview of recent phase 2 and 3 clinical trials. Lim D; Kleitsch J; Werth VP Expert Opin Emerg Drugs; 2023 Dec; 28(4):257-273. PubMed ID: 37860982 [TBL] [Abstract][Full Text] [Related]
19. Improvement in Cutaneous Lupus Erythematosus After Twenty Weeks of Belimumab Use: A Systematic Review and Meta-Analysis. Kneeland R; Montes D; Endo J; Shields B; Bartels CM; Garg S Arthritis Care Res (Hoboken); 2023 Aug; 75(8):1838-1848. PubMed ID: 36358025 [TBL] [Abstract][Full Text] [Related]
20. Recent advances in cytokines in cutaneous and systemic lupus erythematosus. Mikita N; Ikeda T; Ishiguro M; Furukawa F J Dermatol; 2011 Sep; 38(9):839-49. PubMed ID: 21767292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]